ARROWHEAD PHARMACEUTICALS COMPLETES ENROLLMENT IN GLOBAL PHASE 3 YOSEMITE STUDY OF ZODASIRAN FOR THE TREATMENT OF HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA

Reuters · 2d ago

Please log in to view news